Membrane Localization of LRRK2 Is Associated with Increased Formation of the Highly Active LRRK2 Dimer and Changes in Its Phosphorylation

被引:166
作者
Berger, Zdenek [1 ,2 ]
Smith, Kelsey A. [1 ]
LaVoie, Matthew J. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Ctr Neurol Dis, Dept Neurol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
DISEASE-ASSOCIATED MUTATIONS; FAMILIAL PARKINSONS-DISEASE; PROTEIN-KINASE ACTIVITY; GAMMA-SECRETASE; LEUCINE-RICH-REPEAT-KINASE-2; LRRK2; GTP-BINDING; COMPLEX; DOMAIN; GENE; PRESENILIN;
D O I
10.1021/bi100157u
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autosomal dominant mutations in leucine rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease (PD). Despite the presence of multiple domains, the kinase activity of LRRK2 is thought to represent the primary function of the protein. Alterations in LRRK2 kinase activity are thought to underlie the pathogenesis of its PD-linked mutations; however, many questions regarding basic aspects of LRRK2 function remain unclear, including the cellular mechanisms of LRRK2 regulation and the importance of its unique distribution within the cell. Here, we demonstrate for the first time that the subcellular localization of wild-type LRRK2 is associated with changes in four distinct biochemical properties likely crucial for LRRK2 function. Our data demonstrate for the first time that the wild-type LRRK2 dimer possesses greater kinase activity than its more abundant monomeric counterpart. Importantly, we show that this activated form of LRRK2 is substantially enriched at the membrane of cells expressing endogenous or exogenous LRRK2, and that the membrane-associated fraction of LRRK2 likewise possesses greater kinase activity than cytosolic LRRK2. In addition, membrane-associated LRRK2 binds GTP more efficiently than cytosolic LRRK2 but demonstrates a lower degree of phosphorylation. Our observations suggest that multiple events, including altered protein protein interactions and post-translational modifications, contribute to the regulation of LRRK2 function, through modulation of membrane association and complex assembly. These Findings may have implications for the sites of LRRK2 function within the cell, the identification and localization of bona fide LRRK2 substrates, and efforts to design small molecule inhibitors of LRRK2.
引用
收藏
页码:5511 / 5523
页数:13
相关论文
共 60 条
[1]   LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model [J].
Alegre-Abarrategui, Javier ;
Christian, Helen ;
Lufino, Michele M. P. ;
Mutihac, Ruxandra ;
Venda, Lara Lourenco ;
Ansorge, Olaf ;
Wade-Martins, Richard .
HUMAN MOLECULAR GENETICS, 2009, 18 (21) :4022-4034
[2]   Investigation of leucine-rich repeat kinase 2 [J].
Anand, Vasanti S. ;
Reichling, Laurie J. ;
Lipinski, Kerri ;
Stochaj, Wayne ;
Duan, Weili ;
Kelleher, Kerry ;
Pungaliya, Pooja ;
Brown, Eugene L. ;
Reinhart, Peter H. ;
Somberg, Richard ;
Hirst, Warren D. ;
Riddle, Steven M. ;
Braithwaite, Steven P. .
FEBS JOURNAL, 2009, 276 (02) :466-478
[3]   Localization of LRRK2 to membranous and vesicular structures in mammalian brain [J].
Biskup, Saskia ;
Moore, Darren J. ;
Celsi, Fulvio ;
Higashi, Shinji ;
West, Andrew B. ;
Andrabi, Shaida A. ;
Kurkinen, Kaisa ;
Yu, Seong-Woon ;
Savitt, Joseph M. ;
Waldvogel, Henry J. ;
Faull, Richard L. M. ;
Emson, Piers C. ;
Torp, Reldun ;
Ottersen, Ole P. ;
Dawson, Ted M. ;
Dawson, Valina L. .
ANNALS OF NEUROLOGY, 2006, 60 (05) :557-569
[4]   Sequence and structure-based prediction of eukaryotic protein phosphorylation sites [J].
Blom, N ;
Gammeltoft, S ;
Brunak, S .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 294 (05) :1351-1362
[5]   How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease [J].
Cookson, MR ;
Xiromerisiou, G ;
Singleton, A .
CURRENT OPINION IN NEUROLOGY, 2005, 18 (06) :706-711
[6]   Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase [J].
Deng, Junpeng ;
Lewis, Patrick A. ;
Greggio, Elisa ;
Sluch, Eli ;
Beilina, Alexandra ;
Cookson, Mark R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (05) :1499-1504
[7]   Genetics of Parkinson disease: paradigm shifts and future prospects [J].
Farrer, MJ .
NATURE REVIEWS GENETICS, 2006, 7 (04) :306-318
[8]   Mixed-lineage kinase control of JNK and p38 MAPK pathways [J].
Gallo, KA ;
Johnson, GL .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (09) :663-672
[9]   The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro [J].
Gloeckner, Christian Johannes ;
Schumacher, Annette ;
Boldt, Karsten ;
Ueffing, Marius .
JOURNAL OF NEUROCHEMISTRY, 2009, 109 (04) :959-968
[10]   The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity [J].
Gloeckner, CJ ;
Kinkl, N ;
Schumacher, A ;
Braun, RJ ;
O'Neill, E ;
Meitinger, T ;
Kolch, W ;
Prokisch, H ;
Ueffing, M .
HUMAN MOLECULAR GENETICS, 2006, 15 (02) :223-232